Paper Details

  1. Home
  2. Paper Details

Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives.

Author: BlannAndrew D, BorianiGiuseppe, LipGregory Y H

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This article discusses the increasing prevalence of atrial fibrillation (AF) and the associated risk of stroke. It highlights the benefits of oral anticoagulants, particularly non-vitamin K antagonist oral anticoagulants (NOACs), in reducing the risk of thromboembolism in patients with AF.
Paper Details　
Original Abstract of the Article :
In the coming decades, the number of Europeans with atrial fibrillation (AF) is set to rise as the population ages, and so with it will the number of strokes. The risk of thromboembolism (principally stroke and systemic embolism) and death can be reduced by the use of the vitamin K antagonists (VKA,...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/europace/euw211

データ提供：米国国立医学図書館（NLM）

The Future of Stroke Prevention: Modeling Edoxaban's Impact on Atrial Fibrillation

As the global population ages, the prevalence of atrial fibrillation (AF) is expected to increase, leading to a rise in stroke cases. This study examines the potential impact of edoxaban, a non-vitamin K antagonist oral anticoagulant (NOAC), on stroke prevention in an aging European population. The researchers used modeling projections to estimate the effects of edoxaban on stroke, thromboembolism, and health economics over the next few decades.

Edoxaban: A Potential Solution for Stroke Prevention

The study predicts a significant reduction in stroke and thromboembolic events with the widespread adoption of edoxaban. The results also highlight the potential economic benefits associated with edoxaban's use, particularly in terms of reduced healthcare costs.

Understanding the Importance of Anticoagulation Therapy

This study underscores the importance of anticoagulation therapy in preventing stroke and thromboembolism in patients with AF. It highlights the need for proactive strategies to manage this growing health concern. It's like preparing for a desert journey – understanding the potential risks and having the right tools can make all the difference.

Dr.Camel's Conclusion

This study offers a glimpse into the future of stroke prevention. It highlights the potential of edoxaban as a valuable tool in combating this growing health concern. As we continue to navigate the vast desert of cardiovascular health, research like this provides us with essential tools to ensure a safer and healthier future.

Date :
  1. Date Completed 2017-03-14
  2. Date Revised 2017-03-14
Further Info :

Pubmed ID

27876695

DOI: Digital Object Identifier

10.1093/europace/euw211

Related Literature

Article Analysis
・Effects of edoxaban
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.